The Gross Margin of Rhythm Pharmaceuticals Inc (RYTM) is 89.73%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 89.73% |
| 2023-12-31 | 87.99% |
| 2022-12-31 | 90.99% |
| 2021-12-31 | 81.27% |